- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05310175
Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression
September 2, 2023 updated by: Zeng Yuxiao, China Academy of Chinese Medical Sciences
Efficacy of Acupuncture at Acupoints Group Around the Base of Skull for Post-Stroke Depression: a Randomized Controlled Trial
The objective of this trial is to evaluate the efficacy and safety of electroacupuncture at acupoints group around the base of skull for post-stroke depression.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
98 eligible participants with post-stroke depression will be recruited and randomly assigned to the experimental group and the control group in a ratio of 1:1.
Participants in both groups will receive electroacupuncture or placebo acupuncture treatment at acupoints group around the base of skull 3 times a week for 4 weeks, and followed up for 24 weeks.
Study Type
Interventional
Enrollment (Estimated)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yuxiao Zeng
- Phone Number: +86-15901278206
- Email: zengyuxiao@aliyun.com
Study Locations
-
-
-
Beijing, China
- Recruiting
- China Academy of Chinese Medical Sciences
-
Contact:
- Yuxiao Zeng
- Phone Number: +86-15901278206
- Email: zengyuxiao@aliyun.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Conforming to the criteria for the diagnosis of PSD recommended by the "Chinese Expert Consensus on Clinical Practice of Post-Stroke Depression";
- Aged 40 to 80 years old;
- The score of HDRS-24 item scale is more than 8 points and less than 35 points, that is, mild to moderate depression;
- Has not received antidepressant treatment or has been discontinued for more than 2 weeks before entering treatment, and has not participated in other ongoing clinical trials.
Exclusion Criteria:
- Subjects with history of mental illness or family history of mental illness;
- Subjects with severe heart, liver, kidney, hematopoietic system, endocrine and immune system diseases;
- Subjects with dementia, aphasia, cognitive dysfunction or unable to cooperate with examination and treatment;
- Subjects installed with the cardiac pacemaker;
- Pregnant or lactating patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
Participants will receive electroacupuncture at Yamen(DU15), bilateral Tianzhu(BL10), Fengchi(GB20), Wangu(GB12), and Yifeng(SJ17) for 30minutes, 3 times a week for 4 weeks.
|
Filiform needles (0.30×50mm, Hanyi brand, Beijing Medical Appliance, China) and the SDZ-V electric acupuncture (Suzhou Medical Appliance) apparatus will be used.
After acupuncture at the acupoints group, the needle handle will be connected with the electrode of the electric acupuncture apparatus.
Other Names:
|
Placebo Comparator: Control group
Participants will receive shallow needle insertion of 2-3 mm at sham acupoints without manipulation for 30minutes, 3 times a week for 4 weeks.
|
Shallow needle insertion of 2-3 mm at sham acupoints without manipulation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change rate of the total score of Hamilton Depression Rating Scale
Time Frame: Baseline, week 4
|
The therapeutic effects are assessed based upon HDRS score-reducing rate. Cure: HDRS score-reducing rate≥75%; Remarkable effect: HDRS score-reducing rate≥50%, <75%; Improvement: HDRS score-reducing rate≥25%, <50%; Failure: HDRS score-reducing rate<25%.
|
Baseline, week 4
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in the scores of HDRS and its seven kinds of factors
Time Frame: Baseline, week4, week16 and week28
|
The change in total score of HDRS and changes in its seven kinds of factors at the end of week4, 16 and 28, compared with baseline.
The HDRS-24 has two scoring methods: total scores and seven-category factor scores.
A total score of 78 points, with higher scores indicating more severe depression: a score below 8 indicates no depression; a score of 8-20 indicates mild depression; a score of 20-35 indicates moderate depression; and a score of more than 35 indicates major depression.
Seven types of factors are anxiety/somatization, weight, cognitive impairment, day and night changes, retardation, sleep disturbance, and sense of hopelessness.
The scores of each category of factors could reflect in which aspect the patients' specific depressive symptoms showed.
|
Baseline, week4, week16 and week28
|
Change in the scores of Beck Depression Inventory (BDI)
Time Frame: Baseline, week4, week16 and week28
|
The change in total score of BDI at the end of week4, 16 and 28, compared with baseline.
The BDI scale has a total score of 63 points, with higher scores indicating more severe depression: A score of 1 to 10 points suggests normal, a score of 11 to 16 points suggests mild emotional disturbance, a score of 17 to 20 points suggests clinically borderline depression, a score of 21 to 30 points suggests moderate depression, and a score of ≥ 31 points suggests severe depression.
|
Baseline, week4, week16 and week28
|
Change in the scores of National Institute of Health stroke scale (NIHSS)
Time Frame: Baseline, week4, week16 and week28
|
The change in total score of NIHSS at the end of week4, 16 and 28, compared with baseline.
The NIHSS mainly evaluates the neurological deficit of stroke patients, which includes 15 items such as cognition, language, sensory, motor, visual field deficit, etc.
The total score is 42 points.
The higher the score, the more serious the neurological deficit.
A score of 0 to 1 indicates normal or nearly normal, a score of 1 to 4 indicates a mild stroke, a score of 5 to 15 indicates a moderate stroke, and a score of > 20 indicates a severe stroke.
|
Baseline, week4, week16 and week28
|
Change in the scores of Barthel Index (BI)
Time Frame: Baseline, week4, week16 and week28
|
The change in total score of BI at the end of week4, 16 and 28, compared with baseline.
The BI scale consists of 10 items that evaluate eating, bathing, daily washing, dressing, urinating, toileting, walking, activity and going up stairs, respectively.
The total score of 100 points is classified as normal.
A higher score indicates better independence and quality of survival of the patient.
|
Baseline, week4, week16 and week28
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Yuxiao Zeng, China Academy of Chinese Medical Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 6, 2022
Primary Completion (Actual)
May 6, 2023
Study Completion (Estimated)
October 1, 2024
Study Registration Dates
First Submitted
March 25, 2022
First Submitted That Met QC Criteria
March 25, 2022
First Posted (Actual)
April 4, 2022
Study Record Updates
Last Update Posted (Estimated)
September 6, 2023
Last Update Submitted That Met QC Criteria
September 2, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ChinaACMS2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-stroke Depression
-
University of CincinnatiRecruitingPost-stroke DepressionUnited States
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingHealthy | Post-stroke DepressionChina
-
Chinese University of Hong KongResearch Grants Council, Hong KongRecruiting
-
Maastricht University Medical CenterCompletedVascular Dementia | Post-stroke Depression | Vascular Cognitive Impairment | Post-stroke Apathy | Post-stroke DementiaNetherlands
-
University Medicine GreifswaldCompletedPost-stroke Depression | Post-stroke AphasiaGermany
-
University Hospital of North NorwayNorwegian Extra Foundation for Health and RehabilitationCompletedStroke | Quality of Life | Fatigue | Cognitive Impairment | Post-stroke Depression | Neuropsychology | Post-Stroke Fatigue | Meta-cognitionNorway
-
Zhujiang HospitalUnknown
-
Tel-Aviv Sourasky Medical CenterCompleted
-
Xiyuan Hospital of China Academy of Chinese Medical...CompletedPost-stroke DepressionChina
Clinical Trials on Electroacupuncture
-
The Second Affiliated Hospital, Guangzhou University...RecruitingDisorder of Consciousness | ElectroacupunctureChina
-
University of California, IrvineRecruiting
-
Guang'anmen Hospital of China Academy of Chinese...Shenzhen Second People's Hospital; Shaanxi Hospital of Traditional Chinese... and other collaboratorsUnknown
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Tianjin Nankai HospitalRecruitingSepsis | Electroacupuncture | Sepsis-associated Brain InjuryChina
-
Cancer Institute and Hospital, Chinese Academy...UnknownAcupuncture | Gastrointestinal FunctionChina
-
Corporacion Parc TauliCompletedFatigue | Inflammatory Bowel DiseaseSpain
-
Guang'anmen Hospital of China Academy of Chinese...Not yet recruitingDysmenorrhea | Adenomyosis | ElectroacupunctureChina
-
Guang'anmen Hospital of China Academy of Chinese...RecruitingChronic Urinary RetentionChina
-
Guang'anmen Hospital of China Academy of Chinese...Ministry of Science and Technology of the People´s Republic of ChinaCompletedMenopausal SyndromeChina